ABL Pharma | PCT | 30 Capsules

ABL Pharma PCT is a focused post-cycle support formula built around three distinct jobs: managing estrogenic rebound pressure, supporting hepatic resilience, and helping maintain a more favorable male-hormone environment during the transition off-cycle. Unlike bloated “test booster” labels that scatter dozens of low-dose botanicals across a panel, this formula takes a narrower, more purposeful approach with three disclosed actives: 75mg Androsta-3,5-Diene-7-17-Dione, 350mg NAC, and 450mg stinging nettle. That matters, because in the PCT category, label transparency is often poor and formulas are frequently padded with generic libido herbs that do little for the actual post-cycle problem.

Androsta-3,5-Diene-7-17-Dione is the centerpiece. Better known in the market as arimistane, this compound is used in advanced sports nutrition for estrogen control. Its role is to help reduce aromatase activity, the enzyme responsible for converting androgens into estrogens. In practical terms, that makes it relevant for users concerned about estrogen-related rebound effects after a cycle, including water retention, softer look, or the subjective drop in “hardness” and confidence many users report. At 75mg, this sits squarely in the range commonly used in PCT-style formulas. This is not a testosterone ingredient in the classic sense; it is a hormonal-environment management ingredient, and customers should understand that distinction.

N-Acetyl Cysteine at 350mg brings a different kind of intelligence to the formula. NAC is a precursor to glutathione, one of the body’s central intracellular antioxidants and a major player in detoxification pathways, especially in the liver. Post-cycle support without liver support is incomplete, particularly for users coming off compounds that place metabolic stress on hepatic systems. The 350mg dose is useful, though it sits below the more aggressive standalone wellness and liver-support dosing commonly seen at 600-1,200mg daily. In this formula, NAC serves as meaningful baseline support rather than a full-spectrum liver protocol. You’re not buying this product for NAC alone, but its inclusion makes mechanistic sense and improves the formula materially.

Stinging nettle at 450mg rounds out the stack with androgen-environment support. Its root extracts are commonly used in men’s health formulas because compounds within nettle appear to interact with sex hormone-binding globulin pathways and are also frequently positioned for prostate support. In a PCT context, that makes it a logical secondary ingredient: not because it replaces core hormonal recovery strategies, but because it supports the environment advanced male users are trying to maintain. At 450mg, this is a respectable working dose for general inclusion in this category.

The synergy here is straightforward and smart. Arimistane addresses estrogen pressure. NAC supports the liver systems that often deserve attention after a cycle. Stinging nettle supports the broader male-hormone and prostate context. Together, they form a minimalist PCT support trio rather than a kitchen-sink formula.

Transparency is a real strength here. There is no proprietary blend, and every active with its dose is disclosed. That is a major advantage in this category, where vague “PCT matrix” labels are common. Day 1, most users will not feel a stimulant-like effect; this is a physiological support product, not a sensory one. Over 2-4 weeks, the experience is subtler: a drier, more controlled transition, better confidence in estrogen management, and the reassurance that liver support is built into the protocol rather than added as an afterthought.

How to Use ABL Pharma | PCT